CD19 and mantle cell lymphoma: Albeit associated with more laborious sample preparation, CD19+ immunomagnetic beads enrichment as performed in the FIL-MCL0208 trial could increase the number of patients eligible for genotyping from PB or BM and might be useful to cover larger cohorts of MCL patients in clinical routine.